Search Results - "Beukelman, Timothy"

Attack phenotypes and disease course in pediatric MOGAD.

Authors: Santoro, Jonathan D. Beukelman, Timothy Hemingway, Cheryl et al.

Source: Annals of Clinical & Translational Neurology. May2023, Vol. 10 Issue 5, p672-685. 14p.

Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?

Authors: Ioannou, Yiannis Beukelman, Timothy Murray, Miranda et al.

Source: European Journal of Rheumatology. Jan2023, Vol. 10 Issue 1, p39-44. 6p.

First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.

Authors: Beukelman, Timothy Tomlinson, George Nigrovic, Peter A. et al.

Source: Pediatric Rheumatology. 12/8/2022, Vol. 20 Issue 1, p1-10. 10p.

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors: Beukelman, Timothy Lougee, Aimee Matsouaka, Roland A. et al.

Source: Pediatric Rheumatology. 8/21/2021, Vol. 19 Issue 1, p1-10. 10p.

Generating Real‐World Evidence From the Excellence Network in Rheumatology.

Authors: Beukelman, Timothy Mudano, Amy Stewart, Patrick et al.

Source: Pharmacoepidemiology & Drug Safety. Dec2024, Vol. 33 Issue 12, p1-7. 7p.

Identifying inpatient mortality in MarketScan claims data using machine learning.

Authors: Xie, Fenglong Beukelman, Timothy Sun, Dongmei et al.

Source: Pharmacoepidemiology & Drug Safety. Nov2023, Vol. 32 Issue 11, p1299-1305. 7p.

Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned.

Authors: Beukelman, Timothy Chen, Lang Annapureddy, Narender et al.

Source: Pharmacoepidemiology & Drug Safety. Sep2023, Vol. 32 Issue 9, p969-977. 9p.

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities.

Authors: Beukelman, Timothy Anink, Janneke Berntson, Lillemor et al.

Source: Pediatric Rheumatology. 4/19/2017, Vol. 15, p1-9. 9p.

The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.

Authors: Beukelman, Timothy Yukiko Kimura Ilowite, Norman T. et al.

Source: Pediatric Rheumatology. 4/17/2017, Vol. 15, p1-10. 10p.

Back mobility and interincisor distance ranges in racially diverse North American healthy children and relationship to generalized hypermobility.

Authors: Woolston, Sophie L Beukelman, Timothy Sherry, David D

Source: Pediatric Rheumatology. 2012, Vol. 10 Issue 1, p17-21. 5p. 1 Black and White Photograph, 1 Diagram, 3 Charts.

Guilt by association--what is the true risk of malignancy in children treated with etanercept for JIA?

Authors: Cron, Randy Q. Beukelman, Timothy

Source: Pediatric Rheumatology. 2010, Vol. 8, p23-25. 3p.

Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm.

Authors: Jackson, Lesley E. Khullar, Nitasha Beukelman, Timothy et al.

Source: Viruses (1999-4915). Oct2023, Vol. 15 Issue 10, p2036. 13p.

Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors: Hahn, Timothy Daymont, Carrie Beukelman, Timothy et al.

Source: Pediatric Rheumatology. 11/25/2022, Vol. 20 Issue 1, p1-8. 8p.

Placeholder TextIntraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors: Hahn, Timothy Daymont, Carrie Beukelman, Timothy et al.

Source: Pediatric Rheumatology. 11/24/2022, Vol. 20 Issue 1, p1-8. 8p.

Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.

Authors: Correll, Colleen Burciu, Alis Bansal, Amita et al.

Source: Pediatric Rheumatology. 10/21/2025, Vol. 23 Issue 1, p1-10. 10p.

Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis.

Authors: Beukelman, Timothy Xie, Fenglong Baddley, John W. et al.

Source: Arthritis & Rheumatism. May2013, Vol. 65 Issue 5, p1384-1389. 6p.

Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases.

Authors: Haynes, Kevin Beukelman, Timothy Curtis, Jeffrey R. et al.

Source: Arthritis & Rheumatism. Jan2013, Vol. 65 Issue 1, p48-58. 11p.

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment.

Authors: Beukelman, Timothy Xie, Fenglong Chen, Lang et al.

Source: Arthritis & Rheumatism. Aug2012, Vol. 64 Issue 8, p2773-2780. 8p.

Rates of Malignancy Associated With Juvenile Idiopathic Arthritis and Its Treatment.

Authors: Beukelman, Timothy Haynes, Kevin Curtis, Jeffrey R. et al.

Source: Arthritis & Rheumatism. Apr2012, Vol. 64 Issue 4, p1263-1271. 9p. 5 Charts.

Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study.

Authors: Stoll, Matthew L. Grubbs, James Aaron Beukelman, Timothy et al.

Source: Pediatric Rheumatology. 11/9/2017, Vol. 15, p1-6. 6p.